Here are four things to know:
1. The companies will create a biomedical manufacturing and market development operation in Japan called OPM Asia.
2. OPM Asia holds an exclusive regional license that allows it to expand in an area which includes Japan, China, Korea, Taiwan, Thailand, Malaysia, Vietnam and India, among other countries.
3. The joint venture will allow the companies to use OPM’s proprietary OsteoFab 3-D printing technology and other materials technology.
4. The manufacturing facility is expected to open before year end and products will be available to the Asian market in the second quarter of 2019. According to Frost & Sullivan, the Asian healthcare industry is projected to surge by more than 11 percent to $517 billion in 2018, one of the world’s fastest rates.
More articles on surface technology:
Zimmer Biomet receives FDA approval for 1st 3D printed titanium spinal implant: 4 points
Life Spine expands PRO-LINK Ti Stand-Alone Cervical Spacer System line: 3 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
